logo
logo
Sign in

Lyophilized Drugs Market Is Estimated To Witness High Growth Owing To Increasing Demand For Long Shelf-Life Drugs

avatar
Leena Shedmake
Lyophilized Drugs Market Is Estimated To Witness High Growth Owing To Increasing Demand For Long Shelf-Life Drugs

Lyophilized drugs, also known as freeze-dried drugs, refer to drugs that have been dehydrated using lyophilization. Lyophilization involves freezing the drug and then reducing the surrounding pressure and allowing the frozen water in the drug to sublime or transition directly from its solid phase to its gas phase. The key benefit of lyophilization is that it leads to long shelf life by removing water from drugs, therefore preventing the growth of microbes. Lyophilized drugs have applications across various therapeutic areas such as oncology, autoimmune diseases, and infectious diseases. For example, they are used for cancer chemotherapy drugs requiring precise dosing.


The global lyophilized drugs market is estimated to be valued at US$ 30 Bn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Dynamics:


One of the key drivers for the growth of the lyophilized drugs market is the increasing demand for drugs with long shelf-life. Lyophilization eliminates the need for refrigeration as it removes water from the drugs, inhibiting microbial growth and preventing degradation. This leads to a shelf life of 2-3 years at room temperature, compared to only a few months for conventionally packaged drugs. The long shelf-life without refrigeration reduces logistical and supply chain complexities, lowering the transportation and storage costs for pharmaceutical companies. Moreover, it also prevents drug wastage from temperature excursions during shipping or in developing countries lacking reliable cold chain infrastructure. The increasing global demand for drugs requiring precise dosing and long shelf-life is expected to propel the growth of the lyophilized drugs market over the forecast period.


SWOT Analysis


Strength: Lyophilized drugs offers improved stability, solubility, and ease of administration compared to conventional forms. The lyophilization process helps extend shelf life and ensure product stability for extended periods without refrigeration. This reduces logistical challenges in transportation and storage of drugs.


Weakness: Lyophilization is a complex and costly process requiring specialized equipment. The equipment has high capital and operating costs which raises production costs. Further, finding optimal lyophilization conditions requires extensive experimentation that increases development timelines.


Opportunity: Growth of biologics and injectable generics provides opportunities for lyophilized drugs. Often biologics tend to be unstable and require lyophilization to improve stability during storage and transportation without refrigeration. The increasing accessibility and affordability of healthcare in developing nations is also supporting market growth.


Threats: Changing regulations can disrupt manufacturing and delay product launches. Stringent requirements to validate lyophilization processes increases compliance burden on manufacturers. Product recalls due to stability issues can negatively impact brand reputation.


Key Takeaways


The Global Lyophilized Drugs Market Size is expected to witness high growth over the forecast period supported by the growing demand for biologics and injectable drugs. Lyophilization offers critical advantages over conventional dosage forms in terms of stability, ease of handling and transportation.


Regional analysis: North America dominates the market backed by the larges consumption of biologics and generic injectables in the region. Stringent quality regulations have prompted drug manufacturers to adopt lyophilization to meet drug stability requirements. Europe and Asia Pacific are also major lyophilized drugs markets supporting various local and multinational players. Asia Pacific market is growing at the fastest pace supported by expanding healthcare sector and rising income levels.


Key players: Key players operating in the lyophilized drugs market are Merck KGaA, Baxter International Inc, Becton, Dickinson and Company, Fresenius Kabi AG, GlaxoSmithKline PLC. These players focus on capacity expansions and new product launches to strengthen market position.


Explore more information on this topic, Please visit-

https://www.dailyprbulletin.com/lyophilized-drugs-market-share-size-and-growth-share-trends-analysis-demand-forecast/


Explore more trending article on this topic:

https://www.dailyprbulletin.com/supply-chain-risk-management-market-share-size-and-growth-share-trends-analysis-demand-forecast/

collect
0
avatar
Leena Shedmake
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more